Long before silicon chips, a Victorian mathematician dreamed of a machine that could run any algorithm imaginable, and in ...

Curated by Canadian distribution veteran Charles Tremblay, the seven-day industry sidebar is set to run Sept 10-16, alongside the Toronto International Film Festival. TIFF has revealed the outline of ...

The Florida Gators on Sunday were officially named the No. 1 seed in the South Region of the NCAA Tournament, beating out Houston and UConn after both lost in their individual conference tournament ...

Gina Carano has built a unique career spanning mixed martial arts and Hollywood. The former MMA star became one of the sport’s early breakout fighters before transitioning to acting, landing roles in ...

Sir: Over the past few years, the presidency has launched multiple metering initiatives, beginning with the National Mass Metering Initiative (NMMI) in October 2020. This programme was designed to end ...

A new report paints a stark picture of how a subset of large healthcare providers is drawing the lion’s share of 340B savings within a single state. The controversial drug discount program has been ...

Nvidia's Jensen Huang said markets "got it wrong" about the software sell-off. Software stocks were rebounding on Thursday as chip stocks, including Nvidia, sold off. Buying beaten-down software ...

Andrej Karpathy wrote that AI had made software "nowhere near 'business as usual.'"Michael Macor/The San Francisco Chronicle via Getty Images Andrej Karpathy has a long list of AI bona fides. He was a ...

AI disruption fears have cooled some for now, but whether stocks can keep a grip on that calm lies heavily at the feet of Nvidia earnings later. It needs to dazzle, or at least not disappoint.

For decades, starting a software business required one of two things: learning to code or raising enough money to hire engineers. Both were major barriers for small business owners, creators, and ...

Check out the companies making headlines before the bell: Moderna — Shares tumbled 10% after the pharma giant said the Food and Drug Administration refused to review its application for an ...